Navigation Links
The Link Between Weight Loss and Heart Failure

Researchers note weight loss is an important predictor of poor outcome in patients with heart failure. But doctors have little to go on // regarding why heart failure patients lose weight or how to put the pounds back on.

The study focused on elevated levels of angiotensin II, a substance in the blood that causes vessels to contract and blood pressure to rise . A study conducted in mice that showed administration of the substance led to significant weight loss and angiotensin II was also linked to a decrease in blood and skeletal muscle levels of insulin-like growth factor 1 (IGF-1).

A more recent study was done by researchers to help clarify how angiotensin II and IGF-1 work to produce weight loss. Using various scientific methods, they showed angiotensin II inhibits IGF-1 signaling in skeletal muscle, which in turn, leads to skeletal muscle loss. They also found a complete reversal of angiotensin-related weight loss in mice that were genetically engineered to produce more than the normal amount of IGF-1.

Thus researchers believe these findings can be used to help develop new treatments for congestive heart failure and other wasting conditions.
'"/>




Page: 1

Related medicine news :

1. Link Between Infection And Heart Disease
2. Prescription Drug Use Varies Widely Between States
3. Wait Between Pregnancies
4. Link Between Migraines and Behavioral Disorders
5. Link Between Obesity and Behavior in Kids
6. Link Between Mothers Depression and Violence in Children
7. Link Between Alcohol and Decrease in Brain Size
8. Link Between Musculoskeletal Pain and Vitamin D Deficiency
9. Link Between Hyperglycemia & Hospital Mortality
10. Link Between Alcohol Consumption And Cardiovascular Disease
11. Understanding The Link Between Hormone Replacement and Respiratory Disease
Post Your Comments:
Breaking Medicine Technology:Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 1Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 2Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 3Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 4Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 5Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 6Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 7Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 14517 1Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 14517 2Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 14517 3New chromosomal abnormality identified in leukemia associated with Down syndrome 10408 1New chromosomal abnormality identified in leukemia associated with Down syndrome 10408 2New chromosomal abnormality identified in leukemia associated with Down syndrome 10408 3